Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CODX NASDAQ:IINN NASDAQ:SINT NYSEAMERICAN:VTAK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCODXCo-Diagnostics$0.38-11.9%$0.34$0.23▼$1.35$16.57M0.9314.65 million shs1.67 million shsIINNInspira Technologies OXY B.H.N.$1.13-7.4%$1.21$0.40▼$1.65$15.40M2.29294,932 shs252,189 shsSINTSintx Technologies$4.14-4.8%$3.95$1.71▼$8.60$15.60M0.83113,469 shs57,511 shsVTAKCatheter Precision$2.76-3.5%$2.76$2.20▼$33.06$4.25M-0.8421,439 shs216,384 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCODXCo-Diagnostics-11.86%-1.28%+23.61%+51.60%-72.13%IINNInspira Technologies OXY B.H.N.-7.38%-5.83%-9.60%-5.83%-19.29%SINTSintx Technologies-4.83%+5.08%-5.05%+24.32%+49.46%VTAKCatheter Precision-3.50%+7.81%+13.11%-39.87%-55.37%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCODXCo-Diagnostics$0.38-11.9%$0.34$0.23▼$1.35$16.57M0.9314.65 million shs1.67 million shsIINNInspira Technologies OXY B.H.N.$1.13-7.4%$1.21$0.40▼$1.65$15.40M2.29294,932 shs252,189 shsSINTSintx Technologies$4.14-4.8%$3.95$1.71▼$8.60$15.60M0.83113,469 shs57,511 shsVTAKCatheter Precision$2.76-3.5%$2.76$2.20▼$33.06$4.25M-0.8421,439 shs216,384 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCODXCo-Diagnostics-11.86%-1.28%+23.61%+51.60%-72.13%IINNInspira Technologies OXY B.H.N.-7.38%-5.83%-9.60%-5.83%-19.29%SINTSintx Technologies-4.83%+5.08%-5.05%+24.32%+49.46%VTAKCatheter Precision-3.50%+7.81%+13.11%-39.87%-55.37%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCODXCo-Diagnostics 2.50Moderate Buy$5.501,351.19% UpsideIINNInspira Technologies OXY B.H.N. 2.00Hold$2.0076.99% UpsideSINTSintx Technologies 2.00Hold$25.00503.86% UpsideVTAKCatheter Precision 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest VTAK, SINT, IINN, and CODX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/9/2025IINNInspira Technologies OXY B.H.N.Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageSell (E+)10/8/2025CODXCo-DiagnosticsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)10/8/2025SINTSintx TechnologiesWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)9/27/2025CODXCo-DiagnosticsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)9/27/2025SINTSintx TechnologiesWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)9/22/2025SINTSintx TechnologiesAscendiant Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$28.00 ➝ $25.009/17/2025CODXCo-DiagnosticsD. Boral CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$10.008/15/2025CODXCo-DiagnosticsD. Boral CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$10.00(Data available from 10/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCODXCo-Diagnostics$3.91M3.73N/AN/A$1.70 per share0.22IINNInspira Technologies OXY B.H.N.N/AN/AN/AN/A$0.34 per shareN/ASINTSintx Technologies$2.89M5.14N/AN/A$2.90 per share1.43VTAKCatheter Precision$420K9.79N/AN/A$25.29 per share0.11Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCODXCo-Diagnostics-$37.64M-$1.15N/AN/AN/A-3,588.33%-69.49%-60.49%11/6/2025 (Estimated)IINNInspira Technologies OXY B.H.N.-$11.05MN/A0.00∞N/AN/AN/AN/AN/ASINTSintx Technologies-$11.02M-$50.56N/A∞N/A-674.05%-256.59%-121.32%11/11/2025 (Estimated)VTAKCatheter Precision-$16.64MN/A0.00N/AN/A-3,150.33%-193.63%-72.09%11/12/2025 (Estimated)Latest VTAK, SINT, IINN, and CODX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails11/6/2025Q3 2025CODXCo-Diagnostics-$0.19N/AN/AN/AN/AN/A8/14/2025Q2 2025CODXCo-Diagnostics-$0.25-$0.23+$0.02-$0.23$0.30 million$0.16 million8/14/2025Q2 2025SINTSintx Technologies-$0.79-$0.91-$0.12-$0.91$0.40 million$0.15 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCODXCo-DiagnosticsN/AN/AN/AN/AN/AIINNInspira Technologies OXY B.H.N.N/AN/AN/AN/AN/ASINTSintx TechnologiesN/AN/AN/AN/AN/AVTAKCatheter PrecisionN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCODXCo-DiagnosticsN/A4.123.83IINNInspira Technologies OXY B.H.N.0.271.150.90SINTSintx TechnologiesN/A2.572.41VTAKCatheter Precision0.190.440.43Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCODXCo-Diagnostics14.99%IINNInspira Technologies OXY B.H.N.12.72%SINTSintx Technologies18.38%VTAKCatheter Precision20.34%Insider OwnershipCompanyInsider OwnershipCODXCo-Diagnostics8.40%IINNInspira Technologies OXY B.H.N.29.40%SINTSintx Technologies4.08%VTAKCatheter Precision1.53%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCODXCo-Diagnostics10038.52 million35.29 millionOptionableIINNInspira Technologies OXY B.H.N.2012.62 million8.91 millionNot OptionableSINTSintx Technologies403.59 million3.44 millionNot OptionableVTAKCatheter Precision141.49 million1.46 millionN/AVTAK, SINT, IINN, and CODX HeadlinesRecent News About These CompaniesCatheter Precision announces two patents to be issued by USPTOSeptember 30, 2025 | msn.comCatheter Precision announces two patents to be issued by USPTOSeptember 30, 2025 | msn.comCatheter Precision, Inc. Announces Two New Patents to be Issued by USPTOSeptember 30, 2025 | globenewswire.comCatheter Precision, Inc.: Catheter Precision Announces Tender Win and First Purchase Order in CroatiaSeptember 10, 2025 | finanznachrichten.deCatheter Precision Announces Tender Win and First Purchase Order in CroatiaSeptember 10, 2025 | globenewswire.comCatheter Precision Announces September 10th, 2025 Record Date for October 10th, 2025 Special Meeting of StockholdersSeptember 4, 2025 | markets.businessinsider.comCatheter Precision, Inc. Announces Record Date for Special Stockholder Meeting on October 10, 2025September 4, 2025 | quiverquant.comQCatheter Precision Announces Introduction of the LockeT Product Line into ItalySeptember 2, 2025 | markets.businessinsider.comCatheter Precision Announces First Procedures in France as LockeT Expansion ContinuesAugust 28, 2025 | globenewswire.comCatheter receives notification of new patent issuance for VIVO product lineAugust 25, 2025 | msn.comCatheter Precision Receives Notification of New Patent Issuance for VIVO Product LineAugust 25, 2025 | finance.yahoo.comCatheter Precision begins enrollment for LockeT Compare StudyAugust 21, 2025 | msn.comCatheter Precision, Inc. Enrolls First Patients in LockeT Compare Study Evaluating Safety of Suture Retention DeviceAugust 21, 2025 | quiverquant.comQCatheter Precision Announces the Start of Enrollment for the LockeT Compare StudyAugust 21, 2025 | globenewswire.comWhy Did Catheter Precision Stock Soar 49% Today?August 19, 2025 | msn.comWhy Is Catheter Precision Stock (VTAK) Up 70% Today?August 19, 2025 | msn.comCatheter Precision Receives Approval for LockeT in the United KingdomAugust 18, 2025 | finance.yahoo.comCatheter Precision Implements 1-for-19 Reverse Stock SplitAugust 15, 2025 | tipranks.comCatheter Precision announces effectiveness of 1-for-19 reverse stock splitAugust 15, 2025 | msn.comCatheter Precision, Inc. Announces Effective Date of 1-for-19 Reverse Stock SplitAugust 15, 2025 | quiverquant.comQNew MarketBeat Followers Over TimeMedia Sentiment Over TimeVTAK, SINT, IINN, and CODX Company DescriptionsCo-Diagnostics NASDAQ:CODX$0.38 -0.05 (-11.86%) Closing price 10/10/2025 04:00 PM EasternExtended Trading$0.38 0.00 (-1.06%) As of 10/10/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.Inspira Technologies OXY B.H.N. NASDAQ:IINN$1.13 -0.09 (-7.38%) Closing price 10/10/2025 04:00 PM EasternExtended Trading$1.15 +0.02 (+1.42%) As of 10/10/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.Sintx Technologies NASDAQ:SINT$4.14 -0.21 (-4.83%) Closing price 10/10/2025 04:00 PM EasternExtended Trading$4.22 +0.09 (+2.05%) As of 10/10/2025 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.Catheter Precision NYSEAMERICAN:VTAK$2.76 -0.10 (-3.50%) Closing price 10/10/2025 04:10 PM EasternExtended Trading$2.64 -0.12 (-4.17%) As of 10/10/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company sells it products through distribution partners, independent sales agents, and direct employees. Catheter Precision, Inc. is based in Fort Mill, South Carolina. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Broadcom Gets Second $420 Target as CPO Win Boosts Outlook AST SpaceMobile's Big Win: Shares Soar on New Deal With Verizon Bassett Furniture: Buy Now, Sit Back, and Collect Dividends Why Amazon’s Prime Day May Be the Catalyst for a Year-End Rally PepsiCo’s Deep Discount Will Soon Evaporate: Buy It While You Can Bargain Alert: DraftKings Is the Most Oversold It’s Ever Been Constellation Brands: Buffett’s $2.2B Bet May Have Hit Bottom How Gamers Are Powering Microsoft’s Next Wave of Growth Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
